Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,135 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04212494Recruiting
Aspirating clot during heart procedure for certain heart attacks
This trial studies whether removing (“aspirating”) a blood clot during an emergency heart procedure works better for people having a specific type of heart attack with a large clot burden. It may help improve blood flow after treatment, but it is only for patients who meet several timing and safety conditions.
Fuzhou, FujianAges 18 years+ - NCT04221737Recruiting
Early breathing support for ARDS using a pressure release ventilator
This study looks at starting a specific type of breathing machine setting early in people with ARDS (a serious lung problem) to see if it improves outcomes. You might be able to take part if you are within 48 hours of needing a breathing tube and meet the lung oxygen criteria.
Guadalajara, JaliscoAges 18–80 - NCT04206215Recruiting
Noninvasive brain stimulation for carpal tunnel pain relief
This study tests whether a noninvasive brain stimulation treatment can reduce chronic carpal tunnel (CTS) pain, especially when pain spreads beyond the usual nerve area. If you have long-lasting CTS pain that hasn’t improved with standard treatments, you may be able to try this therapy while being closely monitored for safety.
Charlestown, MassachusettsAges 18–80 - NCT04216927RecruitingPhase 3
Neonates on heart-lung bypass get NO to prevent kidney injury
This Phase 3 study tests whether not giving nitric oxide during heart-lung bypass in newborns helps reduce the risk of acute kidney injury. It focuses on newborns having heart surgery for congenital heart disease.
Cincinnati, OhioAges 1 day–1 month - NCT04146870Recruiting
Nutrition check after bone marrow transplant
This trial studies nutrition and nutritional status in people after a bone marrow (hematopoietic stem cell) transplant. It may help the hospital understand what nutritional support works best during recovery.
Suzhou, JiangsuAges 15–80 - NCT04185974Recruiting
Carbon ion re-irradiation for returning head and neck cancer
This trial tests a type of radiation called carbon-ion re-irradiation for people whose head and neck cancer has come back or grown again after earlier radiation. It may help control the cancer after certain surgeries, but it also requires specific safety conditions about timing, prior treatment areas, and overall health.
HeidelbergAges 18 years+ - NCT04207580Recruiting
Follow-up study for children with newly diagnosed nephrotic syndrome
This study follows children in France who developed idiopathic nephrotic syndrome after 2018, to learn how the condition behaves over time. It may help doctors improve future care by tracking symptoms and outcomes.
AgenAges Up to 18 years - NCT04207814Recruiting
Studying causes of repeated pregnancy loss in otherwise unexplained cases
This study looks for possible reasons why some pregnancies end in miscarriage or stillbirth when no clear cause is found. It involves tests and information from both partners, which may help guide future care for couples like yours.
BrestAges 18–40 - NCT04150458Enrolling by invitationPhase 3
PET/CT scan test for tumors using a special tracer
This Phase 3 study tests whether a PET/CT scan using a tracer called 18F-fluorocholine can better identify tumors. It may help doctors more accurately find and characterize tumors to guide treatment.
Montreal, QuebecAges 18–110 - NCT04195425Recruiting
Breastfeeding study on newborn gut health
This study looks at how breastfeeding may affect a baby’s gut (digestive) health. It enrolls parents during pregnancy and follows the family after birth to collect information and samples, to better understand what supports healthy development.
LilleAges 18 years+ - NCT04195347RecruitingPhase 1/Phase 2
CM4620 to lessen pancreatitis after asparaginase
This study tests CM4620 to reduce how severe pancreatitis becomes in children and young people with leukemia/lymphoma who develop pancreatitis after receiving a drug called asparaginase. It aims to improve outcomes by calming the inflammation of the pancreas.
Charlotte, North CarolinaAges Up to 21 years - NCT04237623RecruitingPhase 2
GM-CSF after transplant using a matched related donor
This Phase 2 study tests whether giving a medicine called GM-CSF after an allogeneic transplant (using a matched related donor) can improve outcomes. Participants must meet health and donor-matching requirements and be eligible to safely receive the treatment and consent to the study.
Atlanta, GeorgiaAges 18–78 - NCT04204863Recruiting
Study of adults treated for a prolonged seizure emergency
This study looks at adults who had a serious, long-lasting seizure emergency called status epilepticus. It aims to better understand what happened and may help improve care for similar patients in the future.
AarauAges 18 years+ - NCT04171856Recruiting
Robotic training to improve movement after stroke
This study tests a robotic rehabilitation program to help improve arm movement after an acute or chronic stroke (and separately studies people with transient global amnesia). It may help by measuring how well patients can learn and control movement during repeated robot-guided sessions.
Yvoir, NamurAges 18–90 - NCT04230109RecruitingPhase 2
Sacituzumab Govitecan for newly diagnosed TNBC
This trial tests a drug called sacituzumab govitecan for people with newly diagnosed triple-negative breast cancer (TNBC) that hasn't been treated yet. The drug targets cancer cells directly to try to stop them from growing.
Boston, MassachusettsAges 18 years+ - NCT04175691Recruiting
Study blood RNA markers after sudden ischemic stroke
This trial looks at blood “RNA markers” (molecules that may reflect brain injury) in people who have had a new ischemic stroke. It may help doctors understand what’s happening in the body soon after stroke and possibly guide future care.
Nanjing, JiangsuAges 18 years+ - NCT04180059RecruitingPhase 1
Anti-DP treatment after stem cell transplant to prevent relapse
This early-phase trial tests an anti-DP medicine given after an allogeneic (donor) stem cell transplant. It aims to improve outcomes by targeting immune cells linked to certain transplant match types and reducing relapse risk.
NantesAges 18–75 - NCT04213547Recruiting
Sleep and blood sugar control in teens with type 2 diabetes
This study looks at how sleep timing and length relate to blood sugar control in teens with type 2 diabetes. It also checks whether teens who meet certain sleep and blood-sugar targets—and can follow sleep tracking—can take part in the study and feedback sessions.
Philadelphia, PennsylvaniaAges 12–20 - NCT04219202Recruiting
Pre-surgery radiation for retroperitoneal soft tissue cancer
This study tests giving special radiation (ions) before surgery for a specific cancer in the back of the abdomen (retroperitoneal soft tissue sarcoma). The goal is to shrink or control the tumor so surgery may be safer or more effective.
HeidelbergAges 18 years+ - NCT04156893RecruitingPhase 1/Phase 2
RH-matched blood transfusions for sickle cell patients
This study tests whether giving red blood cells matched to your child’s RH (a blood marker) can improve safety and fit for people with sickle cell disease who need regular transfusions. It may help reduce mismatches by using blood units selected to match the child’s blood type more closely.
Philadelphia, PennsylvaniaAges 6 months+ - NCT04227314RecruitingPhase 3
Apremilast vs placebo for severe recurrent mouth ulcers
This Phase 3 trial tests whether apremilast can reduce severe, recurring mouth ulcers compared with an inactive placebo. It aims to improve ulcer frequency and pain while carefully checking safety.
AmiensAges 18 years+ - NCT04185038RecruitingPhase 1
CAR T therapy through a catheter for pediatric brain tumors
This Phase 1 trial tests a personalized immune-cell treatment (CAR T) delivered directly in the brain-area space using a catheter. It may help children and young adults with hard-to-treat (recurrent or refractory) diffuse midline brain tumors like DIPG/DMG when standard options aren’t working.
Seattle, WashingtonAges 1–26 - NCT04230785Recruiting
Blood RNA test during clot-busting treatment for stroke
This trial studies special molecules in the blood (non-coding RNA) in people having an acute ischemic stroke treated with a procedure to remove clots. It may help doctors better understand how the body responds and potentially improve future stroke care.
Nanjing, JiangsuAges 18–90 - NCT04182984Recruiting
Compare immunosuppressant medicines for eye-only myasthenia gravis
This real-world study looks at how different immunosuppressant medicines work for people with non-thymoma ocular myasthenia gravis (eye symptoms due to MG). It may help doctors understand which treatments control symptoms best in everyday care.
Xi'an, ShaanxiAges 18–75
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,135 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.